• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VALIANT CAPTIVIA; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VALIANT CAPTIVIA; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number VAMF3838C200TU
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Codes No Consequences Or Impact To Patient (2199); Injury (2348)
Date of Event 01/23/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
A valiant stent graft system was implanted in a patient for the endovascular treatment of a thoracic aortic aneurysm (300mm in length from the lsa to sma).It was reported that on follow up ct a type ia endoleak was observed.As per the physician, the cause of the event was anatomy related due to angulation of the vessel.No additional clinical sequelae were reported and the patient will be monitored by their physician.
 
Additional Manufacturer Narrative
Film evaluation summary; the exact cause of the reported proximal type i endoleak could not be determined from the pre-implant films provided.Images during implant and post-implant were not available, and the reported endoleak could not be assessed.A returned pre-implant 3d-ct film report confirmed the taa within the proximal portion of the descending thoracic, beginning just below the steeply angulated <(><<)>(><(>&<)><(><<)>)> short aortic arch.The thoracic diameter along the 25mm proximal seal length ranged from 31.8 to 29.7mm.It is possible that implanting within the short length seal and angulated arch may have contributed to the reported type ia endoleak.Additional information was received for this case: intervention was performed.A proximal extension was implanted and the endoleak has resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALIANT CAPTIVIA
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key7282112
Report Number2953200-2018-00258
Device Sequence Number16178738
Product Code MIH
UDI-Device Identifier00643169346550
UDI-Public00643169346550
Combination Product (Y/N)N
Initial Reporter StateOR
Initial Reporter CountryUS
PMA/510(K) Number
P100040
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/21/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/20/2019
Device Model NumberVAMF3838C200TU
Device Catalogue NumberVAMF3838C200TU
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/02/2018
Initial Date Received by Manufacturer 01/26/2018
Supplement Date Received by Manufacturer03/02/2018
Initial Report FDA Received Date02/20/2018
Supplement Report FDA Received Date03/21/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age71 YR
-
-